Tenoxicam loaded hyalcubosomes for osteoarthritis
Authors:
- 1 May 2021
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 601, 120483
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Clinically important improvement in the WOMAC and predictor factors for response to non-specific non-steroidal anti-inflammatory drugs in osteoarthritic patients: a prospective studyBMC Research Notes, 2012
- Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis – meta-analysisOsteoarthritis and Cartilage, 2011
- Epidemiology of OsteoarthritisClinics in Geriatric Medicine, 2010
- Physicochemical characterization of solid dispersion systems of tadalafil with poloxamer 407Acta Pharmaceutica, 2009
- Improving Tenoxicam Solubility and Bioavailability by Cosolvent SystemAAPS PharmSciTech, 2009
- Vesicle Transformations Resulting from Curvature Tuning in Systems with Micellar, Lamellar, and Bicontinuous Cubic PhasesJournal of Dispersion Science and Technology, 2007
- Physical functioning over three years in knee osteoarthritis: Role of psychosocial, local mechanical, and neuromuscular factorsArthritis & Rheumatism, 2003
- Aqueous dispersions of cubic lipid–water phasesCurrent Opinion in Colloid & Interface Science, 2000
- Glyceryl Monooleate Cubic Phase Gel as Chemical Stability Enhancer of Cefazolin and CefuroximePharmaceutical Development and Technology, 1998
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990